SARS CTL vaccine candidates; HLA supertype‐, genome‐wide scanning and biochemical validation

Abstract:  An effective Severe Acute Respiratory Syndrome (SARS) vaccine is likely to include components that can induce specific cytotoxic T‐lymphocyte (CTL) responses. The specificities of such responses are governed by human leukocyte antigen (HLA)‐restricted presentation of SARS‐derived peptide...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Tissue Antigens
Main Authors: Sylvester‐Hvid, C., Nielsen, M., Lamberth, K., Røder, G., Justesen, S., Lundegaard, C., Worning, P., Thomadsen, H., Lund, O., Brunak, S., Buus, S.
Formato: Artigo
Idioma:Inglês
Publicado em: Munksgaard International Publishers 2004
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7161580/
https://ncbi.nlm.nih.gov/pubmed/15104671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.0001-2815.2004.00221.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados